X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
index medicus (42) 42
animals (39) 39
mice (26) 26
hematology (25) 25
cell line, tumor (20) 20
hemic and lymphatic diseases (19) 19
oncology (19) 19
cancer (15) 15
female (15) 15
protein kinase inhibitors - pharmacology (15) 15
research (15) 15
article (14) 14
male (14) 14
mutation (14) 14
abridged index medicus (12) 12
genetic aspects (12) 12
leukemia (12) 12
acute myeloid-leukemia (10) 10
chronic myelogenous leukemia (10) 10
expression (10) 10
middle aged (9) 9
radiology, nuclear medicine & medical imaging (9) 9
acute lymphoblastic-leukemia (8) 8
cell biology (8) 8
myeloid neoplasia (8) 8
phosphorylation (8) 8
tyrosine (8) 8
apoptosis - drug effects (7) 7
cell line (7) 7
cell proliferation - drug effects (7) 7
mice, inbred balb c (7) 7
protein-tyrosine kinases - antagonists & inhibitors (7) 7
proteins (7) 7
pyrimidines - pharmacology (7) 7
signal transduction - drug effects (7) 7
tyrosine kinase (7) 7
adult (6) 6
analysis (6) 6
benzamides (6) 6
cancer research (6) 6
dasatinib (6) 6
disease models, animal (6) 6
gene expression (6) 6
imatinib mesylate (6) 6
internal tandem duplication (6) 6
leukemia, myeloid, acute - genetics (6) 6
myeloproliferative disorders - genetics (6) 6
patients (6) 6
peripheral vascular disease (6) 6
polycythemia-vera (6) 6
aged (5) 5
antineoplastic agents - pharmacology (5) 5
apoptosis (5) 5
bone marrow transplantation (5) 5
care and treatment (5) 5
cells, cultured (5) 5
chronic myeloid leukemia (5) 5
chronic myeloid-leukemia (5) 5
diagnosis (5) 5
drug resistance, neoplasm (5) 5
flow cytometry (5) 5
genetic research (5) 5
identification (5) 5
janus kinase 2 - genetics (5) 5
kinases (5) 5
leukemia, myeloid, acute - pathology (5) 5
mice, scid (5) 5
multidisciplinary sciences (5) 5
myeloid leukemia (5) 5
piperazines - pharmacology (5) 5
protein-tyrosine kinases - genetics (5) 5
signal transduction (5) 5
swine (5) 5
activating mutation (4) 4
activation (4) 4
acute myeloid leukemia (4) 4
alleles (4) 4
antineoplastic agents - therapeutic use (4) 4
biochemistry & molecular biology (4) 4
blotting, western (4) 4
bone marrow (4) 4
c-kit (4) 4
cell survival - drug effects (4) 4
cell transformation, neoplastic - genetics (4) 4
cell transformation, neoplastic - metabolism (4) 4
chronic lymphocytic-leukemia (4) 4
chronic myelomonocytic leukemia (4) 4
cml (4) 4
fms-like tyrosine kinase 3 - genetics (4) 4
fusion (4) 4
gene mutations (4) 4
health aspects (4) 4
hematopoietic-cells (4) 4
imatinib (4) 4
leukemia - genetics (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - genetics (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - pathology (4) 4
leukemia, myeloid, acute - drug therapy (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


10/2013, ISBN 081668006X, 184
War lays bare death and our relation to it. And in the wars-or more precisely the memories of war-of the twentieth century, images of the deaths of countless... 
Death | War | Sociology | Philosophy
eBook
Oncotarget, ISSN 1949-2553, 05/2018, Volume 9, Issue 37, pp. 24576 - 24589
In many malignancies, the tumor microenvironment includes CSF1R-expressing supportive monocyte/macrophages that promote tumor cell survival. For chronic... 
Chronic lymphocytic leukemia | Tumor microenvironment | Small-molecule inhibitors | Colony-stimulating factor 1 receptor | Tumor-associated macrophages
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 19, pp. 1781 - 1790
Journal Article
Blood, ISSN 0006-4971, 01/2011, Volume 117, Issue 2, pp. 591 - 594
Phosphatidylinositol-3-kinase p110 delta serves as a central integration point for signaling from cell surface receptors known to promote malignant B-cell... 
PHOSPHOINOSITIDE 3-KINASE P110-DELTA | HEMATOLOGY | ANTIGEN RECEPTOR | Lymphoid Neoplasia | Brief Report
Journal Article
Cancer Cell, ISSN 1535-6108, 2009, Volume 16, Issue 5, pp. 401 - 412
Inhibition of BCR-ABL by imatinib induces durable responses in many patients with chronic myeloid leukemia (CML), but resistance attributable to kinase domain... 
CHEMBIO | HUMDISEASE | CHRONIC MYELOGENOUS LEUKEMIA | DASATINIB BMS-354825 | MESYLATE | CML | ONCOLOGY | KINASE DOMAIN MUTATIONS | AMN107 | IMATINIB RESISTANCE | NILOTINIB | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Crystallography, X-Ray | Pyridazines - pharmacology | Protein Kinase Inhibitors - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Antineoplastic Agents - pharmacology | Fusion Proteins, bcr-abl - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Proto-Oncogene Proteins c-abl - genetics | Cell Growth Processes - drug effects | Proto-Oncogene Proteins c-abl - chemistry | Models, Molecular | Imidazoles - pharmacology | Antineoplastic Agents - chemistry | Mice, SCID | Pyridazines - chemistry | Fusion Proteins, bcr-abl - genetics | Animals | Signal Transduction - drug effects | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Proto-Oncogene Proteins c-abl - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Fusion Proteins, bcr-abl - metabolism | Chronic myeloid leukemia | BCR protein | Imatinib | Mutagenesis | Abl protein | Mutation | Fusion protein | Tumors | Index Medicus | imatinib resistance | dasatinib | nilotinib | compound mutation
Journal Article
by Tyner, Jeffrey W and Tognon, Cristina E and Bottomly, Daniel and Wilmot, Beth and Kurtz, Stephen E and Savage, Samantha L and Long, Nicola and Schultz, Anna Reister and Traer, Elie and Abel, Melissa and Agarwal, Anupriya and Blucher, Aurora and Borate, Uma and Bryant, Jade and Burke, Russell and Carlos, Amy and Carpenter, Richie and Carroll, Joseph and Chang, Bill H and Coblentz, Cody and d’Almeida, Amanda and Cook, Rachel and Danilov, Alexey and Dao, Kim-Hien T and Degnin, Michie and Devine, Deirdre and Dibb, James and Edwards, David K and Eide, Christopher A and English, Isabel and Glover, Jason and Henson, Rachel and Ho, Hibery and Jemal, Abdusebur and Johnson, Kara and Johnson, Ryan and Junio, Brian and Kaempf, Andy and Leonard, Jessica and Lin, Chenwei and Liu, Selina Qiuying and Lo, Pierrette and Loriaux, Marc M and Luty, Samuel and Macey, Tara and MacManiman, Jason and Martinez, Jacqueline and Mori, Motomi and Nelson, Dylan and Nichols, Ceilidh and Peters, Jill and Ramsdill, Justin and Rofelty, Angela and Schuff, Robert and Searles, Robert and Segerdell, Erik and Smith, Rebecca L and Spurgeon, Stephen E and Sweeney, Tyler and Thapa, Aashis and Visser, Corinne and Wagner, Jake and Watanabe-Smith, Kevin and Werth, Kristen and Wolf, Joelle and White, Libbey and Yates, Amy and Zhang, Haijiao and Cogle, Christopher R and Collins, Robert H and Connolly, Denise C and Deininger, Michael W and Drusbosky, Leylah and Hourigan, Christopher S and Jordan, Craig T and Kropf, Patricia and Lin, Tara L and Martinez, Micaela E and Medeiros, Bruno C and Pallapati, Rachel R and Pollyea, Daniel A and Swords, Ronan T and Watts, Justin M and Weir, Scott J and Wiest, David L and Winters, Ryan M and McWeeney, Shannon K and Druker, Brian J
Nature, ISSN 0028-0836, 10/2018, Volume 562, Issue 7728, pp. 526 - 531
Journal Article
Blood, ISSN 0006-4971, 06/2010, Volume 115, Issue 25, pp. 5232 - 5240
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 06/2011, Volume 10, Issue 6, pp. 1028 - 1035
Journal Article
Blood, ISSN 0006-4971, 12/2011, Volume 118, Issue 24, pp. 6392 - 6398
Journal Article
Journal Article